Incannex Company Overview

Incannex is a global biotech
company developing
cannabinoid and psychedelic
compound medicines.
Our mission is to deliver novel drugs and therapies that transform
the lives of patients currently experiencing unmet medical needs.
We aim to develop targeted medicines at the cutting edge of
biomedical science and cultural acceptance, creating long term
benefit for both our targeted patients and shareholders who
co-invest in our vision.
– Listed on the ASX in 2016
– Listed on the NASDAQ in 2022